Physician profile
Sean Michael Keyes
NPI 1104112689
$82,336.60
in general payments reported to CMS, 2019-2025
14 companies · $27K in 2025
The $27K reported for 2025 was more than what 97% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,492 · 2020: $27.19 · 2021: $1,331 · 2022: $17K · 2023: $18K · 2024: $14K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Food and Beverage: $2,347 · Travel and Lodging: $1,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,812.50 |
| Food and Beverage | $2,346.62 |
| Travel and Lodging | $1,716.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $71,370.06 | 2022-2025 | |
| Arthrex, INC. | $5,304.71 | 2019-2023 | |
| Reel Surgical, INC. | $3,614.55 | 2021-2022 | |
| Stryker Corporation | $1,343.04 | 2019-2025 | T2, Pangea, Mako |
| Wright Medical Technology, INC. | $237.47 | 2019 | |
| Orthofix Medical, INC. | $118.89 | 2021 | |
| Alexion Pharmaceuticals, INC. | $112.47 | 2024 | |
| Smith+Nephew, INC. | $58.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $41.26 | 2024-2025 | Exparel, Iovera |
| Theragen, INC. | $39.73 | 2020-2021 | |
| Wishbone Medical INC. | $37.43 | 2023 | |
| Depuy Synthes Sales INC. | $25.39 | 2022 | |
| Embody, INC. | $22.19 | 2022 | |
| Lifenet Health | $11.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.